Reuters
Chile approves J&J’s COVID-19 vaccine for emergency use
Chile’s Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson. The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI). “This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,” the institute said in a statement.
